Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Medicine|December 20, 2015
Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsYu-Mu Chen, Chien-Hao Lai, Huang-Chih Chang, et al.
Biomedical Journal|September 3, 2014
Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistinYu-Mu Chen, Wen-Feng Fang, Hsu Ching Kao, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
The impact of clinical parameters on progression-free survival of non-small cell lung cancer patients harboring EGFR-mutations receiving first-line EGFR-tyrosine kinase inhibitorsYu-Mu Chen, Chien-Hao Lai, Huang-Chih Chang, et al.
Respiratory Research|March 5, 2025
Increased autophagy activity regulated by LC3B gene promoter DNA methylation is associated with progression to active pulmonary tuberculosis diseaseYung-Che Chen, Ying-Tang Fang, Chao-Chien Wu, et al.
The Journal of Infection|September 15, 2014
Aberrant Toll-like receptor 2 promoter methylation in blood cells from patients with pulmonary tuberculosisYung-Che Chen, Chang-Chun Hsiao, Chung-Jen Chen, et al.
The Journal of Infection|September 3, 2022
Next generation sequencing reveals miR-431-3p/miR-1303 as immune-regulating microRNAs for active tuberculosisYung-Che Chen, Chang-Chun Hsiao, Chao-Chien Wu, et al.
American Journal of Translational Research|May 5, 2017
Histone H3K14 hypoacetylation and H3K27 hypermethylation along with HDAC1 up-regulation and KDM6B down-regulation are associated with active pulmonary tuberculosis diseaseYung-Che Chen, Tung-Ying Chao, Sum-Yee Leung, et al.
Nutrients|November 27, 2021
Body Mass Index, Weight Loss, and Mortality Risk in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Focus on EGFR MutationYu-Mu Chen, Chien-Hao Lai, Chiung-Yu Lin, et al.
Plos One|August 28, 2015
Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsYu-Mu Chen, Chien-Hao Lai, Huang-Chih Chang, et al.
Plos One|February 20, 2016
Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsYu-Mu Chen, Chien-Hao Lai, Huang-Chih Chang, et al.
Pageof 4